To submit your design, email it to [email protected] or mail it to the Kentucky Department of Veterans Affairs, ATTN: ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

In a recent report, Colliers noted that in Jakarta, the average retail rent remained steady at IDR 564,400 as of Q4 2024. The decision to maintain current renta ...